ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Senior Scientist Single Cell Assay and Technology Development at Xaira Therapeutics - ApplyBlast

Senior Scientist Single Cell Assay and Technology Development

Xaira Therapeutics

11 days ago

South San Francisco, California, United States

Onsite

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Senior Scientist role on Xaira’s High-throughput Biology team focuses on inventing and developing single-cell assays for AI-driven drug discovery. The position involves creating new molecular readouts, extending commercial technologies, and owning the development of reproducible workflows for high-throughput data generation. This role requires collaboration with biologists, engineers, and computational scientists to rapidly design, prototype, and test new assays that power machine-learning models.

Responsibilities

Invent and develop single-cell assays for AI-driven drug discovery
Develop and troubleshoot assay components from sample preparation through NGS library preparation
Build mammalian cell systems and functional assays using cell engineering and flow cytometry

Skills

Qualifications

PhD in molecular biology, cell biology, bioengineering, biochemistry, immunology, or a related field

About Xaira Therapeutics

xaira.com

Headquarters

Lafayette, California, United States

Company Size

1-10 employees

Founded

2023

View Profile

Xaira Therapeutics is a drug discovery and development company that uses artificial intelligence to accelerate the creation of life‑changing medicines. They build computational methods, models, datasets, platforms and disciplined processes to transform drug discovery from an artisanal craft into an engineering discipline with greater certainty and success. Xaira leverages these AI‑driven approaches to generate novel therapeutics aimed at delivering better outcomes for patients in need.